711 results on '"de Knegt, Robert J"'
Search Results
2. Patient profiled data for treatment decision-making: valuable as an add-on to hepatitis C clinical guidelines?
3. Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction
4. An international multidisciplinary consensus statement on MAFLD and the risk of CVD
5. The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
6. Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
7. Association of HBsAg levels with differential gene expression in NK, CD8 T, and memory B cells in treated patients with chronic HBV
8. Sustained response and HBsAg loss after nucleo(s)tide analogue discontinuation in chronic hepatitis B patients: the prospective SNAP study
9. Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes
10. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
11. Spleen Stiffness Measurement Across the Spectrum of Liver Disease Patients in Real-World Practice
12. Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence country
13. End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients
14. Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study
15. B cell activation gene signature in blood and liver of HBeAg+ immune active chronic hepatitis B patients
16. SAT-200-YI Statin use is associated with liver fibrosis regression in the general population: a longitudinal analysis of The Rotterdam Study
17. TOP-241-YI Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants
18. FRI-209 Differential prevalence and prognostic value of metabolic syndrome components among metabolic-dysfunction associated steatotic liver disease (MASLD) patients
19. SAT-035 The yield of routine post-operative doppler ultrasound to detect early post-liver transplantation vascular complications
20. FRI-200 Magnitude of steatotic liver disease before and after liver transplantation and the impact of immunosuppressive medication: a multidimensional study
21. SAT-197-YI Higher serum vitamin D levels is associated with lower MASLD prevalence and incidence: the Rotterdam study
22. SAT-462-YI The interplay between steototic liver disease and viral infections: systematic review, meta-analysis and data synthesis
23. Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam study
24. Screening for fibrosis to diagnose liver diseases early: the LIVERSCREEN project
25. Minimal Development of Liver Fibrosis in Adult Tolerant Liver Transplant Recipients Late After Immunosuppressive Drug Weaning and Transplantation
26. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination
27. LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
28. Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults
29. Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B
30. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B
31. Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection
32. Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population
33. Objectives, design and main findings until 2020 from the Rotterdam Study
34. Prevalence of hepatitis delta virus among chronic hepatitis B carriers in a large tertiary center in the Netherlands
35. Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease
36. Sustained response and HBsAg loss after nucleo(s)tide analogue discontinuation in chronic hepatitis B patients: the prospective SNAP study
37. The Yield of Routine Post-Operative Doppler Ultrasound to Detect Early Post-Liver Transplantation Vascular Complications
38. The new international nomenclature for steatotic liver disease: One step forward towards enhanced awareness for healthier life
39. Epigenome-wide association meta-analysis of DNA methylation with coffee and tea consumption
40. Sex-specific normal values and determinants of infrarenal abdominal aortic diameter among non-aneurysmal elderly population
41. Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study
42. Diagnostic and analytical performance of the hepatitis B core related antigen immunoassay in hepatitis B patients
43. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies
44. Adherence to quality criteria improves concordance between transient elastography and ElastPQ for liver stiffness assessment—A multicenter retrospective study
45. Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study.
46. Nonalcoholic fatty liver disease, liver fibrosis, and structural brain imaging: The Cross‐Cohort Collaboration.
47. A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report.
48. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
49. Nonalcoholic fatty liver disease, liver fibrosis, and structural brain imaging: The Cross‐Cohort Collaboration
50. Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.